Incyte Corporation Earnings

Incyte Corporation’s revenue jumped 19.53% since last year same period to $1052.9Mn in the Q1 2025. On a quarterly growth basis, Incyte Corporation has generated -10.67% fall in its revenue since last 3-months.

Incyte Corporation’s net profit fell -6.69% since last year same period to $158.2Mn in the Q1 2025. On a quarterly growth basis, Incyte Corporation has generated -21.37% fall in its net profits since last 3-months.

Incyte Corporation’s net profit margin fell -21.93% since last year same period to 15.03% in the Q1 2025. On a quarterly growth basis, Incyte Corporation has generated -11.98% fall in its net profit margins since last 3-months.

Incyte Corporation’s price-to-earnings ratio after this Q1 2025 earnings stands at 342.25.

Incyte Corporation’s earning per share (EPS) estimates for the current quarter stand at 0.84 - a -45.96% fall from last quarter’s estimates.

Incyte Corporation’s earning per share (EPS) estimates for the current year stand at 0.84.

Incyte Corporation’s earning per share (EPS) jumped 81.25% since last year same period to 1.16 in the Q1 2025. This indicates that the Incyte Corporation has generated 81.25% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Incyte Corporation’s return on assets (ROA) stands at 0.02.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Incyte Corporation’s return on equity (ROE) stands at 0.